Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 22, Issue 6, 2007, Pages 779-789

  Buchmann, Inga ^a   Riedmüller, Karen ^a   Hoffner, Simone ^a   Mack, Ulrich ^a   Aulmann, Sebastian ^a   Haberkorn, Uwe ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

123I scintigraphy; 18F fluoro 2 doxy glucose; Breast cancer; Pertechnetate; TcO 4 scintigraphy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; PERTECHNETIC ACID TC 99M; SODIUM IODIDE SYMPORTER; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CALCULATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCINTIGRAPHY; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION; BODY POSTURE; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; LABORATORY DIAGNOSIS; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SUPINE POSITION; THORAX TUMOR;

ADULT; AGED; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PRONE POSITION; SENSITIVITY AND SPECIFICITY; SODIUM PERTECHNETATE TC 99M; SUPINE POSITION; THORACIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 37549066294     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.358     Document Type: Article

References (25)

1. Carrasco N. Iodide transport in the thyroid gland. Biochem Biophys Acta 1993;1154:65.
2. - symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res 2004;10:4294.
3. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med; 2000;6:871.
4. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 2006;155:495.
5. 99mTc- pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol 2001;28:829.
6. 67Ga-citrate. J Nucl Med 1975;16:293.
7. Brown RS, Goodman TM, Zasadny KR, et al. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol 2002;29:443.
8. Aloj L, Caraco C, Jagoda E, et al. Glut-1 and hexokinase expression: Relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res 1999;59:4709.
9. Ravazoula P, Batistatou A, Aletra C, et al. Immunohistological expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes. Eur J Gynaecol Oncol 2003;24:544.
10. Scheidhauer K, Walter C, Seemann MD. FDG-PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. Eur J Nucl Med Mol Imaging 2004;31(Suppl. 1):S70.
11. Dose J, Bleckmann C, Bachmann S, et al. Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients. Nucl Med Commun 2002;23:857.
12. Yutani K, Tatsumi M, Uehara T, et al. Effect of patients' being prone during FDG-PET for the diagnosis of breast cancer. AJR Am J Roentgenol 1999;173:1337.
13. Kumar R, Loving VA, Chauhan A, et al. Potential of dual-time-point imaging to improve breast cancer diagnosis with F-18-FDG PET. J Nucl Med 2005;46:1819.
14. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or onternal mammary metastases in breast-cancer. J Clin Oncol 2001;19(15):3516.
15. 99mTc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses. Radiology 1973;106:441.
16. Villarreal RL, Parkey RW, Bonte FJ. Experimental pertechnetate mammography. Radiology 1974;111:657.
17. - symporter (NIS): Imaging and therapeutic applications. Sem Nucl Med 2004;24:23.
18. Shin K, Tomita M, Lonnerdal B. Identification of lactoperoxidase in mature human milk. J Nutr Biochem 2000;11:94.
19. Flanagan FL, Dehdashti F, Siegel BA. PET in breast cancer. Semin Nucl Med 1998;28(4):290.
20. Avril N, Dose J, Janicke F, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol 1996;14:1848.
21. 18F] fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 2003;30:267.
22. Ishimori T, Saga T, Mamede M, et al. Increased [F-18]-FDG uptake in a model of inflammation: Concavalin A-mediated lymphocyte activation. J Nucl Med 2002;43:658.
23. Jones HA, Cadwalladar KA, White JF, et al. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: Implications for interpretation of [F-18]FDG PET images. J Nucl Med 2002;43:652.
24. Takamochi K, Yoshida J, Murakami K. Pitfalls in lymph node staging with positron emission tomography in non-small-cell lung cancer patients. Lung Cancer 2005;47:235.
25. Hamberg LM, Hunter GJ, Alpert NM. The dose-uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification? J Nucl Med 1994;35:1308.